Postmastectomy radiotherapy for all node positive patients: The case against

Postmastectomy radiotherapy for all node positive patients: The case against

Postmastectomy radiotherapy (PMRT) is accepted as the standard of care for women with early breast cancer with 4 or more involved axillary nodes. However the role of PMRT in women with 1–3 involved nodes remains controversial and guidelines vary. We present the arguments against advocating postmaste...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of surgical oncology 2021-10, Vol.47 (10), p.2515-2520
Hauptverfasser: Dixon, J.M., Kunkler, I.H., Russell, N., Thomssen, C.
Format: Artikel
Sprache:eng
Schlagworte:
Antineoplastic Agents - therapeutic use
Axilla
Breast cancer
Breast Neoplasms - pathology
Breast Neoplasms - radiotherapy
Breast Neoplasms - therapy
Chemotherapy, Adjuvant
Female
Humans
Lymphatic Metastasis
Mastectomy
Neoadjuvant Therapy
Neoplasm Micrometastasis
Neoplasm Recurrence, Local - prevention & control
Patient Selection
Postmastectomy radiotherapy
Postoperative Period
Practice Guidelines as Topic
Radiotherapy, Adjuvant - adverse effects
Survival Rate
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Postmastectomy radiotherapy (PMRT) is accepted as the standard of care for women with early breast cancer with 4 or more involved axillary nodes. However the role of PMRT in women with 1–3 involved nodes remains controversial and guidelines vary. We present the arguments against advocating postmastectomy radiotherapy for all women with node positive breast cancer.
ISSN:0748-7983
1532-2157
DOI:10.1016/j.ejso.2021.06.025